Spinosad Topical
ApprovedRecruiting 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Scabies
Conditions
Scabies
Trial Timeline
Mar 4, 2022 → Mar 31, 2026
NCT ID
NCT05310734About Spinosad Topical
Spinosad Topical is a approved stage product being developed by Inotiv for Scabies. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05310734. Target conditions include Scabies.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05310734 | Approved | Recruiting |
Competing Products
3 competing products in Scabies
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam | Viatris | Phase 2 | 49 |
| Permethrin | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Permethrin Cream, 5% + Elimite | Mayne Pharma Group | Phase 3 | 69 |